Dr. Heidi Overton, chosen by President Trump to lead the FDA, struggles to gain Senate committee support for her nomination. The Senate Health, Education, Labor, and Pensions Committee is set to vote, but Overton lacks backing, particularly from Republicans. Democrats are not expected to support her.
The White House recognizes the challenge and is considering alternative candidates. Discussions include potential acting commissioners, bypassing the Senate confirmation process.
Overton’s nomination faces opposition due to her stances on mifepristone, an FDA-approved chemical abortion drug, and her role in Trump’s pro-vaping policies. Senator Josh Hawley questions her commitment to a long-promised safety study of mifepristone. The Susan B. Anthony group, against abortion, urges Senate delay and seeks to ban mail-order mifepristone.
Republican Senators Susan Collins and Lisa Murkowski, who support abortion access, have not disclosed their voting intentions. Acting commissioners remain a consideration as the FDA influences about 20% of consumer spending.
Senator Roger Marshall, a doctor who lost re-election, is reportedly interested in the FDA role. Overton is among Trump’s high-profile nominees struggling for support as GOP congressional control wanes.
Recently, Hung Cao, Trump’s Navy Secretary nominee, received bipartisan scrutiny over military operations management. Senator Thom Tillis opposes Eric Ueland for the Government Accountability Office, citing his involvement with OMB in budget cuts.
Kyle Diamantas currently acts as FDA Commissioner after Marty Makary’s White House ousting, attributed to pressure over flavored vapes. Dr. Makary resisted approving fruit-flavored vapes despite pressure from tobacco interests.
President Trump, during his 2024 campaign, advocated for vaping as a smoking alternative, though serious health effects have been noted.
Senator Bill Cassidy, HELP Committee Chair, expresses concern about acting commissioner installations versus a confirmed commissioner’s independence. Cassidy remains undecided on Overton’s nomination, citing her past association with Trump’s child vaccine reduction efforts as problematic.
Overton stood with Trump for a misleading executive order on vaccines, as no health officials corrected Trump’s errors. Calley Means, a former adviser to RFK Jr., urges opposition to Overton’s nomination, criticizing her resistance to MAHA policies.
Overton’s supporters highlight her medical expertise and former FDA commissioners’ endorsements. The Senate vote on her and other health officials is scheduled for Wednesday.

Amy Klobuchar Takes On Governorship with Promises for Minnesota’s Growth
Challenges of Signature Requirements for Political Candidates in Illinois
Debate Rekindled Over Gray Wolves and Livestock Losses
White House Faces Backlash Over Controversial Video
Former Press Secretary Critiques Republican Strategies